| Literature DB >> 2385884 |
J P Jarow1, J A Kirkland, D G Assimos.
Abstract
Antisperm antibodies are significant in male factor infertility. The prevalence of antisperm antibodies in the infertile population is approximately 10 percent, and it is not cost-effective to test for these antibodies in every male partner of an infertile marriage. Earlier studies have demonstrated a higher prevalence of antisperm antibodies among men with a history of bacterial prostatitis or urethritis. Because of this established association, we measured the prevalence of serum antisperm antibodies, using a gel agglutination assay, in 28 men with chronic nonbacterial prostatitis and in age-matched control group of 69 men without a history of prostatitis. The prevalence was 25 percent (test subjects) and 7.2 percent (controls) (p less than 0.05). This finding indicates that nonbacterial prostatitis is a risk factor for the presence of serum antisperm antibodies and that subfertile men with a history of nonbacterial prostatitis should be tested for these antibodies.Entities:
Mesh:
Substances:
Year: 1990 PMID: 2385884 DOI: 10.1016/0090-4295(90)80215-9
Source DB: PubMed Journal: Urology ISSN: 0090-4295 Impact factor: 2.649